TIDMFUM

RNS Number : 1158I

Futura Medical PLC

14 June 2017

 
 For immediate release   14 June 2017

Futura Medical plc

("Futura" or "the Company")

Result of AGM

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, confirms that all resolutions were duly passed at its Annual General Meeting held today.

For any further information please contact:

 
 Futura Medical plc 
 James Barder, Chief Executive                  Tel: +44 (0)1483 685 
                                                                 670 
 mail to: james.barder@futuramedical.com       www.futuramedical.com 
 
 N+1 Singer (Nominated Adviser 
  and Broker) 
 Aubrey Powell / Liz Yong                   Tel:+44 (0) 20 7496 3000 
 
 For media enquiries please 
  contact: 
 Buchanan 
 Mark Court / Sophie Cowles                 Tel: +44 (0)20 7466 5000 
  / Stephanie Watson

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGUSVVRBNANAAR

(END) Dow Jones Newswires

June 14, 2017 12:00 ET (16:00 GMT)

Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Futura Medical Charts.
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Futura Medical Charts.